Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Duke's Califf Tapped For FDA Deputy Post; Some See Succession Planning

This article was originally published in The Gray Sheet

Executive Summary

Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. He may be being groomed to become the next commissioner, agency watchers suggest.


Related Content

Califf Maintains Desire To Stay At US FDA, But Will Either Presidential Candidate Keep Him?
Commissioner Califf: Cardiologist, Clinical Trials Expert Ascends At FDA
FDA Ready To Hire New Deputy Commissioner For Medical Products And Tobacco
FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office
Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties
FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus
FDA Has Regulatory Science Plan; Now It Needs Funding
Duke’s Califf Bows Out Of FDA Search; Quest Moves To Baltimore, New York
IRB Reform Is Low-Hanging Fruit For FDA-Duke Clinical Trial Initiative
Larger Clinical Studies Required To Assess Device Risk/Benefit – Duke’s Califf


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts